These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3622088)

  • 21. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial.
    Lai CL; Ching CK; Tung AK; Li E; Young J; Hill A; Wong BC; Dent J; Wu PC
    Hepatology; 1997 Jan; 25(1):241-4. PubMed ID: 8985298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
    Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A
    Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of chronic active hepatitis caused by hepatitis B virus infection].
    Degos F; Marcellin P; Benhamou JP
    Gastroenterol Clin Biol; 1988 Nov; 12(11):845-54. PubMed ID: 2464521
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antiviral treatment of chronic hepatitis].
    Müller R
    Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
    [No Abstract]   [Full Text] [Related]  

  • 25. The controversial role of lamivudine prophylaxis in occult HBV carriers treated with chemo-immune therapy.
    D'Andrea M; Nosotti L; Pimpinelli F; Dessanti ML; Paviglianiti A; Miglioresi L; Morrone A; Petti MC
    Dig Liver Dis; 2009 Nov; 41(11):839-40. PubMed ID: 19464241
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of chronic hepatitis B].
    Sogni P; Molinié C; Lapprand M
    Ann Gastroenterol Hepatol (Paris); 1988; 24(3):117-22. PubMed ID: 2456710
    [No Abstract]   [Full Text] [Related]  

  • 27. Current concepts in viral hepatitis.
    Hoofnagle JH
    Arq Gastroenterol; 1979; 16(3):124-32. PubMed ID: 94994
    [No Abstract]   [Full Text] [Related]  

  • 28. Short-term prednisone in chronic hepatitis B.
    Gheorghescu B
    Gastroenterology; 1984 Jul; 87(1):249. PubMed ID: 6724270
    [No Abstract]   [Full Text] [Related]  

  • 29. Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma.
    Enomoto M; Nishiguchi S; Seki S; Yamane T; Hino M
    Am J Gastroenterol; 2004 Aug; 99(8):1619-20. PubMed ID: 15307884
    [No Abstract]   [Full Text] [Related]  

  • 30. Introduction to 'Hepatitis B virus heterogeneity--a means to personalized care'.
    Bonino F;
    Antivir Ther; 2010; 15 Suppl 3():1-2. PubMed ID: 21041898
    [No Abstract]   [Full Text] [Related]  

  • 31. Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy.
    Tseng TC; Liu CJ; Hsieh SC; Chen PJ; Lai MY; Chen DS; Kao JH
    Dig Liver Dis; 2009 Apr; 41(4):322-3. PubMed ID: 18848814
    [No Abstract]   [Full Text] [Related]  

  • 32. [Consensus document of the Spanish Association for the Study of the Liver on the treatment of hepatitis B infection (2012)].
    Buti M; García-Samaniego J; Prieto M; Rodríguez M; Sánchez-Tapias JM; Suárez E; Esteban R
    Gastroenterol Hepatol; 2012; 35(7):512-28. PubMed ID: 22749508
    [No Abstract]   [Full Text] [Related]  

  • 33. Effectiveness of adenine arabinoside 5'-monophosphate in kidney transplant recipients with chronic active hepatitis B.
    Pol S; Saltiel C; Legendre C; Carnot F; Driss F; Berthelot P; Bréchot C; Ruet C; Kreis H
    Nephrol Dial Transplant; 1994; 9(7):820-3. PubMed ID: 7526277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hepatitis B carrier state.
    Murray BJ
    Am Fam Physician; 1986 Apr; 33(4):127-33. PubMed ID: 2938461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of chronic hepatitis B].
    Carreño V; Montaño L; Torres M
    Rev Clin Esp; 1983 Oct; 171(1):73-6. PubMed ID: 6197728
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapy of chronic hepatitis B].
    Piontek M; Stremmel W
    Z Gastroenterol; 1989 Mar; 27(3):151-2. PubMed ID: 2718536
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pathogenic mechanism of fulminant hepatic failure in HBs Ag carrier after withdrawal of cytotoxic chemotherapy].
    Inoue K; Yoshiba M; Sekiyama K; Koh I; Fujita R
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):467-72. PubMed ID: 12442428
    [No Abstract]   [Full Text] [Related]  

  • 38. [Course of chronic virus hepatitis B in children and attempts at modifying its treatment].
    Kowalik-Mikołajewska B
    Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):258-60. PubMed ID: 7694262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Advances in the treatment of acute hepatitis B].
    Mochida S; Fujiwara K
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():248-52. PubMed ID: 15453324
    [No Abstract]   [Full Text] [Related]  

  • 40. Human lymphoblastoid and fibroblast interferon in the treatment of chronic hepatitis B.
    Hayashi J; Noguchi A; Nakashima K; Hayashi S; Kashiwagi S; Mayumi T; Motomura M
    Clin Ther; 1990; 12(1):12-21. PubMed ID: 2328524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.